Nicole Gordon, MD
Surgery · Bakersfield, CANPI 1255575965
Payments from drug & device makers
What this record shows
29 manufacturers reported payments, led by Axogen at 49.4% of the total. 2025 is the largest year on record at $1,962, more than ten times the $65 reported in 2020.
Across 56 payments — averaging $68.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- Stryker$674
- Icad, Inc$153
- Endomagnetics Ltd$121
- Johnson & Johnson$119
- GSK$100
- plus $767 from 23 others
What the payments were for
- Travel & lodging$2,05054%
- Food & beverage$1,77146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 5 | $1,887 |
| Stryker | 2 | $674 |
| Icad, Inc | 3 | $153 |
| Endomagnetics Ltd | 1 | $121 |
| Johnson & Johnson(2 entities) | 5 | $119 |
| GSK | 3 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Tactile Systems Technology Inc | 1 | $65 |
| Genentech USA, Inc. | 3 | $57 |
| Seagen Inc. | 3 | $49 |
| Novartis | 2 | $45 |
| Bristol Myers Squibb | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $42 |
| Myriad Genetic Laboratories, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Karyopharm Therapeutics Inc. | 2 | $37 |
| Incyte Corporation | 2 | $36 |
| Applied Medical Resources Corporation | 1 | $32 |
| Eisai Inc. | 1 | $24 |
| Amgen | 1 | $23 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Morphosys, US Inc. | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXOGUARD$3,665
- AXOGUARD HA+ NERVE PROTECTOR$1,832
- AxoGuard Nerve Cap$1,832
- SPY-PHI SYSTEM$643
- Magseed$121
- Magtrace$121
How this compares
$3,821 in reported general payments places this provider in the 60th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 22 | $50 |
Paid to pharmacies, not to this prescriber.
Other surgery in Bakersfield
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
- Beemen KhalilPalo Alto$1.1M
- John LiphamLos Angeles$942K
- Alexander NedopilLodi$682K
- Barry GardinerSan Ramon$602K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.